Ginkgo Bioworks shareholders elect all 9 directors and approve auditor and say-on-pay at 2024 annual meeting

Ginkgo Bioworks Holdings, Inc.

Quorum of ~82.93% combined Class A and Class B shares; ~92.33% of Class B shares present.
All nine director nominees elected: Jason Kelly, Reshma Shetty, Arie Belldegrun, Ross Fubini, Kathy Hopinkah Hannan, Christian Henry, Myrtle Potter, Shyam Sankar, Harry E. Sloan.
Ratification of Deloitte & Touche as independent auditor for FY 2024 approved with 4,898,828,240 votes for.
Advisory vote to approve executive compensation passed with 4,583,064,713 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.